Children's of Alabama (CoA)

1600 7th Avenue South
Birmingham, Alabama 35233

We've found

1 trials

at this facility

Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension

Status: Enrolling, Phase III
Updated: 4/19/2018

from

Birmingham, AL

Use our guide to learn which trials are right for you!